Global protein chip Market

Protein Chip Market Size, Share, Growth Analysis, By Technology(Analytical microarrays, functional protein microarrays, and reverse phase protein microarrays), By Application(Diagnostics, proteomics, and antibody characterization), By End user(Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & Biotechnological Companies), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2149 | Region: Global | Published Date: March, 2024
Pages: 198 | Tables: 91 | Figures: 76

Protein Chip Market News

  • In April 2023, Swedish researchers developed a microfluidic chip that they hope will allow for easier monitoring of monoclonal antibody (mAb) production. The protein cartridge, developed by a team from KTH Royal Institute of Technology in Stockholm, allows for the simultaneous analysis of up to four different proteins in the cell culture in a bioreactor.
  • In February 2023, recombinant protein expression was widely used in clinical diagnostics, vaccine development, and drug discovery. However, efficiently producing fully functional proteins at a high throughput often faces challenges due to misfolding. Sengenics addresses this with KREXTM technology, utilizing Biotin Carboxyl Carrier Protein (BCCP) to enhance folding and solubility. This innovation enables high-throughput expression of correctly folded proteins. The technology is tailored for simultaneous evaluation of numerous mutant proteins using Sengenics KREXTM platform, assessing how small molecules can restore mutated protein function.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Protein Chip Market size was valued at USD 713.06 Million in 2022 and is poised to grow from USD 766.54 Million in 2023 to USD 1,367.11 million by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).

The protein chip market is marked by a blend of established players and emerging entrants striving for innovation and market expansion. Leading companies are consistently engaged in research and development activities to enhance their product portfolios, focusing on improvements in microarray technology, detection methods, and data analysis. Partnerships, collaborations, and strategic acquisitions are common strategies employed to gain a competitive edge and broaden market presence. Additionally, customization and application-specific solutions are becoming pivotal as end-users seek tailored protein chip platforms. 'Agilent Technologies (US)', 'PerkinElmer (US)', 'Bio-Rad Laboratories (US)', 'Thermo Fisher Scientific (US)', 'Sigma-Aldrich Corporation (US)', 'Illumina (US)', 'GE Healthcare (US)', 'Bruker Corporation (US)', 'Shimadzu Corporation (Japan)', 'Roche Diagnostics (Switzerland)', 'RayBiotech (US)', 'Gyros Protein Technologies (UK)', 'Innopsys (France)', 'Randox Laboratories (UK)', 'HORIBA, Ltd. (Japan)', 'CapitalBio Corporation (China)', 'Biotech Support Group (US)', 'Surmodics (US)', 'PerkinElmer (US)', 'Innova Biosciences (UK)'

The modern world has experienced a notable shift in lifestyle, leading to a significant increase in the occurrence of cancer. Factors such as rising alcohol consumption, tobacco use, and substance abuse have contributed to this trend. Moreover, the prevalent sedentary way of life has resulted in a decline in physical activity, consequently leading to obesity—a primary catalyst for numerous chronic lifestyle-related ailments. This sedentary lifestyle, coupled with the consumption of highly processed, sugary, and nutritionally deficient foods from proliferating fast-food chains, has compounded the issue, even leading to diabetes in the population. Additionally, environmental elements like air pollution have played a role in the escalating cancer rates.

Rowing Demand for Personalized Medicine: The shift towards personalized medicine has fueled the demand for protein chips, as they allow for the analysis of individual protein profiles and biomarkers. This enables healthcare providers to tailor treatments based on patients' unique molecular characteristics, leading to more effective outcomes.

North America held the largest significant share in the protein chip market, as the region boasts a robust research infrastructure, advanced technological capabilities, and significant investments in healthcare and biotechnology. Established pharmaceutical and biotech companies, along with top-tier academic institutions, drive the demand for protein chips for drug discovery, disease profiling, and biomarker identification. Additionally, favorable government initiatives, substantial funding for research projects, and a high adoption rate of cutting-edge technologies contribute to North America's leadership in the protein chip market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global protein chip Market

Report ID: SQMIG35H2149

$5,300
BUY NOW GET FREE SAMPLE